Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в червні 1993 (uk)
- im Juni 1993 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xunu de 1993 (ast)
- scientific article published on 01 June 1993 (en)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - E D Crawford
- S E Rivkin
- W S Fletcher
- M Boileau
- B A Blumenstein
- A J Wozniak
|
rdfs:label
| - Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study (en)
- Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study (nl)
|
skos:prefLabel
| - Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study (en)
- Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study (nl)
|
name
| - Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study (en)
- Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study (nl)
|
title
| |
title
| - Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1002/1097-0142(19930615)71:12<3975::AID-CNCR2820711229>3.0.CO;2-D
|
is about
of | |
is cites work
of | |
is cites work
of | |